Thirteen-year-old Oran Knowlson from the UK, who suffers from Lennox-Gastaut syndrome, has made medical history.

Oran became the first patient globally to have a neurostimulator device implanted in his skull at Great Ormond Street Hospital.

The Picostim neurostimulator was developed through a collaboration involving UCL, GOSH, King's College London, the University of Oxford, and Amber Therapeutics.

The device emits continuous pulses of current to block abnormal brain signals, achieving an 80% reduction in Oran's seizures.

Consultant paediatric neurosurgeon Martin Tisdall led the procedure.

The neurostimulator has significantly improved Oran's quality of life, enabling him to engage in activities such as horse riding.

This treatment sends electrical signals deep into the brain and reduces daytime seizures.

The success of the procedure represents a significant advancement in epilepsy treatment and offers hope for others with severe epilepsy.

There is potential for deep brain stimulation to become a standard treatment for pediatric epilepsy in the future.